Search hospitals > Arkansas > Little Rock
Veterans Affairs Medical Center - Little Rock (McClellan)
Claim this profileLittle Rock, Arkansas 72205
Global Leader in Lung Cancer
Global Leader in Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
111 reported clinical trials
7 medical researchers
Summary
Veterans Affairs Medical Center - Little Rock (McClellan) is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Leukemia, Lymphoma and other specialties. Veterans Affairs Medical Center - Little Rock (McClellan) is involved with conducting 111 clinical trials across 137 conditions. There are 7 research doctors associated with this hospital, such as Rangaswamy Govindarajan, Ryan Dare, MD, Matt Burns, MD, and Barry Uretsky, MD.Area of expertise
1Lung Cancer
Global LeaderStage I
Stage II
Stage III
2Cancer
Global LeaderStage IV
Stage I
Stage II
Top PIs
Rangaswamy GovindarajanJohn L McClellan Memorial Veterans Hospital6 years of reported clinical research
Studies Cancer
Studies Lung Cancer
9 reported clinical trials
41 drugs studied
Ryan Dare, MDCentral Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR8 years of reported clinical research
Studies Clostridium
Studies C. Difficile
1 reported clinical trial
3 drugs studied
Matt Burns, MDCentral Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR8 years of reported clinical research
Studies Clostridium
Studies C. Difficile
1 reported clinical trial
3 drugs studied
Barry Uretsky, MDCentral Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR1 year of reported clinical research
Studies Atherosclerosis
Studies Prediabetes
1 reported clinical trial
2 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Little Rock (McClellan)
Non-Small Cell Lung Cancer
Lung Cancer
Multiple Myeloma
Plasma Cell Neoplasms
ALK Gene Rearrangement
Diabetic Kidney Disease
Skin Cancer
Cutaneous Melanoma
Cancer
Recurrence
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Ramucirumab + Pembrolizumab vs Chemotherapy
for Non-Small Cell Lung Cancer
This phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that may prevent the growth of new blood vessels that tumors need to grow. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help doctors find out if giving ramucirumab with pembrolizumab is more effective at treating patients with stage IV or recurrent non-small cell lung cancer than standard chemotherapy.
Recruiting2 awards Phase 310 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Little Rock (McClellan)?
Veterans Affairs Medical Center - Little Rock (McClellan) is a medical facility located in Little Rock, Arkansas. This center is recognized for care of Lung Cancer, Cancer, Non-Small Cell Lung Cancer, Leukemia, Lymphoma and other specialties. Veterans Affairs Medical Center - Little Rock (McClellan) is involved with conducting 111 clinical trials across 137 conditions. There are 7 research doctors associated with this hospital, such as Rangaswamy Govindarajan, Ryan Dare, MD, Matt Burns, MD, and Barry Uretsky, MD.